Samsara BioCapital’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-432,000
| Closed | -$3.45M | – | 42 |
|
|
2023
Q3 | $3.45M | Hold |
432,000
| – | – | 1.06% | 26 |
|
|
2023
Q2 | $3.76M | Sell |
432,000
-48,000
| -10% | -$418K | 0.66% | 24 |
|
|
2023
Q1 | $1.41M | Hold |
480,000
| – | – | 0.29% | 37 |
|
|
2022
Q4 | $1.68M | Hold |
480,000
| – | – | 0.36% | 33 |
|
|
2022
Q3 | $3.8M | Hold |
480,000
| – | – | 0.89% | 26 |
|
|
2022
Q2 | $3.78M | Hold |
480,000
| – | – | 1.01% | 24 |
|
|
2022
Q1 | $5.83M | Hold |
480,000
| – | – | 1.47% | 16 |
|
|
2021
Q4 | $5.88M | Buy |
480,000
+30,000
| +7% | +$367K | 1.14% | 20 |
|
|
2021
Q3 | $4.69M | Hold |
450,000
| – | – | 0.74% | 29 |
|
|
2021
Q2 | $4.05M | Hold |
450,000
| – | – | 0.5% | 29 |
|
|
2021
Q1 | $4.57M | Buy |
+450,000
| New | +$4.57M | 0.84% | 26 |
|